DTI Suspends Sales of 5 E-cigarette Brands in Philippines, Including LOST MARY, Chillax, SHFTDr.Freeze, Aerogin, Don Bars, Black Elite

Regulations by 2FIRSTS.ai
Sep.09.2024
DTI Suspends Sales of 5 E-cigarette Brands in Philippines, Including LOST MARY, Chillax, SHFTDr.Freeze, Aerogin, Don Bars, Black Elite
DTI suspends sales of five e-cigarette brands in the Philippines for allegedly violating e-cigarette law.

On September 6, the Department of Trade and Industry (DTI) of the Philippines issued a notice suspending the sale of five e-cigarette brands, including LOST MARY, Chillax, SHFT Dr. Freeze, Aerogin, Don Bars, and Black Elite, for allegedly violating e-cigarette laws.

 

The announcement states that these brands have been formally charged with violating Section 4(d) of Republic Act No. 11900, also known as the "Vaporized Nicotine and Non-Nicotine Products Regulation Act.

 

According to the announcement, based on Article 11 of Executive Order No. 913 issued in 1983, the transactions of these brands will be suspended until the formal charges are released. At the same time, the product standard licenses (PS licenses) of several brands have also been suspended. The penalty for a first offense is 2 million pesos (approximately 36,000 US dollars), 4 million pesos for a second offense, and 5 million pesos and license revocation for a third offense.

 

The Department of Trade and Industry (DTI) of the Philippines has announced that the Office of the Special Concerns for Nicotine and Non-Nicotine Products, Devices, and Novel Tobacco Products (OSMV) has also released a policy guideline regarding Republic Act No. 11900. The guideline specifies illegal elements to ensure the orderly implementation of regulations and provide a uniform and predictable approach to formal charges.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
As nicotine pouches gain global traction as a lower-risk alternative to smoking, questions are emerging about their potential oral health effects. In a 2Firsts interview, Stingfree AB founder Bengt Wiberg discusses why gum irritation and oral lesions warrant closer scrutiny within the broader framework of tobacco harm reduction.
Jan.06
Coalition pushes back on Hochul’s proposed 75% wholesale tax on alternative nicotine products
Coalition pushes back on Hochul’s proposed 75% wholesale tax on alternative nicotine products
A coalition of business owners and former law enforcement officers protested Gov. Kathy Hochul’s proposed 75% wholesale tax on alternative nicotine products, saying it would fuel organized crime and burden low-income New Yorkers, while supporters said it would curb addiction and help fund hospitals.
Feb.28 by 2FIRSTS.ai
China to Cancel VAT Export Rebates on E-Cigarette Products from April 1, 2026
China to Cancel VAT Export Rebates on E-Cigarette Products from April 1, 2026
China’s Ministry of Finance and State Taxation Administration have announced adjustments to export tax rebate policies, placing nicotine-containing non-combustible inhalation products within the scope of items subject to rebate cancellation. The measures will take effect from April 1, 2026.
Regulations
Jan.10
3,200 suspected "drug-laced cigarettes" seized in Johor Bahru, case value estimated at US$242,500
3,200 suspected "drug-laced cigarettes" seized in Johor Bahru, case value estimated at US$242,500
Malaysian police seized 3,200 suspicious e-pods with ketamine liquid, arresting two men in Johor Bahru's drug distribution bust.
Feb.04 by 2FIRSTS.ai
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire reported a sharp year-on-year revenue decline in Q2 FY2026 as it shifted away from lower-quality customers, while cutting operating expenses and narrowing its net loss. The company also highlighted improved collections, with net accounts receivable down nearly one-fifth since June 30, 2025, alongside ongoing manufacturing and technology initiatives.
Feb.09 by 2FIRSTS.ai